Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-26 @ 1:25 AM
NCT ID:
NCT03852433
Pre Assignment Details:
258 participants were screened. Participants were assigned to arms A: Pegylated Interferon Alfa-2a (PEG-IFN Alfa), B: Bulevirtide 2 mg/Day + PEG-IFN Alfa, C: Bulevirtide 10 mg/Day + PEG-IFN Alfa and D: Bulevirtide 10 mg/Day to the respective treatment.
Recruitment Details:
Participants were enrolled at study sites in the France, Moldova, Romania and Russia.
Study:
NCT03852433
Study Brief:
Results Section:
NCT03852433